AptarGroup, Inc.

NYSE:ATR

Medical - Instruments & Supplies

Healthcare
$141.67 +0.55%

+$0.66 today

Market cap
$8.98B
Beta
0.40
P/E (TTM)
20.0
EPS (TTM)
$6.04
Dividend yield
1.57%
52W Low $103.23High $164.28

Volume 0.34M

Average 0.51M

ATR Common Stock

The par or stated value of issued common shares, plus paid-in capital where reported together.

AptarGroup, Inc.NYSE: ATR

Common Stock · Q2 FY2026 · quarter ended Jun 2026

Common stock broadly unchanged from a year ago

Common stock stood at $732K at the end of Q2 FY2026, up 0.7% from a year earlier and up 0.1% from the prior quarter. Over 3 fiscal years it compounded at +0.9% a year.

Context

  • Common stock amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
  • Common stock increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether common stock keeps rising in the next quarterly balance sheet after a +0.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$732K+0.1% QoQ
Last fiscal yearDec 2025
$728K+0.4% YoY
Year agoJun 2025
$727K+0.7% since
Common Stock past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.7%——
1 year+0.4%——
3-year CAGR+0.9%——
5-year CAGR——
10-year CAGR——

Common Stock history

USD · from the balance sheet

Latest · FY2025
728K USD
Year-over-year change
+0.4%
4-year CAGR
+0.8%

Common Stock vs competitors

How ATR compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +0.7% is the highest of 7, against a peer median of +0.0%.
  • Common stock amounts to 0.0% of total assets for ATR, versus a peer median of 0.0%.
ATR Competitors
Common Stock for ATR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
AMCRAmcor plcJun 2026$23M USD+0.0%+18.0%0.1%
STVNStevanato Group S.p.A.Jun 2026€22.23M EUR+0.0%+0.8%0.8%
WSTWest Pharmaceutical Services, Inc.Jun 2026$18.8M USD+0.0%+0.0%0.5%
SLGNSilgan Holdings Inc.Jun 2026$1.75M USD+0.0%+0.0%0.0%
ATRAptarGroup, Inc.Jun 2026$732K USD+0.7%+0.9%0.0%
TRSTriMas CorporationMar 2026$360K USD-12.2%-3.3%0.0%
SONSonoco Products CompanySep 2026$0 USD-100.0%+0.0%0.0%
Peer median (excluding ATR) —+0.0%+0.0%0.0%

Competitors are the stored peer set for ATR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents122.93M141.73M223.64M223.84M402.42M
Short-term Investments740K002.34M7.11M
Net Receivables671.35M676.99M677.82M658.06M803.83M
Inventory441.46M486.81M513.05M461.81M537.85M
Other Current Assets0124.77M134.76M13.64M142.35M
Total Current Assets1.36B1.43B1.55B1.48B1.89B
Property, Plant & Equipment (Net)1.34B1.4B1.54B1.51B1.74B
Goodwill974.16M945.63M963.42M936.26M1.08B
Intangible Assets362.34M315.74M283.21M254.77M255.34M
Long-term Investments59.49M52.31M49.2M146.27M131.03M
Tax Assets00000
Other Non-current Assets48.84M57.14M69.64M105.24M152.71M
Total Non-current Assets2.78B2.77B2.9B2.95B3.36B
Total Assets4.14B4.2B4.45B4.43B5.25B
Account Payables285.26M320.28M328.57M295.97M340.56M
Short-term Debt285.88M122.79M458.22M338.29M343.53M
Tax Payables00000
Deferred Revenue86.95M80.24M60.51M64.43M74.83M
Other Current Liabilities195.31M206.33M222.01M211.44M232.6M
Total Current Liabilities982.49M917.18M1.25B1.07B1.17B
Long-term Debt907.02M1.05B681.19M688.07M1.14B
Deferred Tax Liabilities27.55M20.56M19.02M14.26M19.65M
Deferred Revenue (Non-current)21.91M25.36M37.76M00
Other Non-current Liabilities169.79M76.61M96.06M126.03M167.03M
Total Non-current Liabilities1.17B1.22B879.28M878.07M1.37B
Total Liabilities2.16B2.14B2.13B1.95B2.54B
Common Stock704K709K717K725K728K
Retained Earnings1.79B1.93B2.11B2.37B2.64B
Accumulated OCI(316.04M)(341.37M)(308.73M)(429.48M)(186.38M)
Other Stockholders Equity00000
Minority Interest15.19M14.27M14.47M14.04M44.13M
Total Equity1.98B2.07B2.32B2.49B2.71B
Total Debt1.24B1.22B1.18B1.08B1.53B
Net Debt1.12B1.08B961.03M852.22M1.13B

AptarGroup, Inc.

NYSE:ATR

Intrinsic Alpha fair value

Locked

Current Price

$141.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.